Ranolazine, a Partial Fatty Acid Oxidation Inhibitor, its Potential Benefit in Angina and Other Cardiovascular Disorders

Publisher： Bentham Science Publishers

E-ISSN： 2212-3962|2|1|35-39

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.2, Iss.1, 2007-01, pp. : 35-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Ranolazine on Cardiovascular System

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 215-221

Bentham Science Publishers

Access to resources Recommend Favorite

Ranolazine and its Antiarrhythmic Actions

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 13, Iss. 1, 2015-01 ,pp. : 31-39

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammation and its Association with Glucose Disorders and Cardiovascular Disease

By Barzilay Joshua   Freedland Eric  

Treatments in Endocrinology, Vol. 2, Iss. 2, 2003-01 ,pp. : 85-94

Adis International

Access to resources Recommend Favorite

Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders

By  

Digestive Diseases, Vol. 33, Iss. 3, 2015-05 ,pp. : 433-439

Karger

Access to resources Recommend Favorite

Metabolic Therapy for Ischemic Heart Disease: The Rationale for Inhibition of Fatty Acid Oxidation

By Stanley William   Sabbah Hani  

Heart Failure Reviews, Vol. 10, Iss. 4, 2005-12 ,pp. : 275-279

Springer Publishing Company

Access to resources Recommend Favorite